Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.5576
-0.0394 (-6.60%)
May 11, 2026, 4:00 PM EDT - Market closed

Oragenics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
235171352
Market Cap Growth
-42.43%-27.94%-73.23%35.85%-75.41%25.99%
Enterprise Value
-3.63-4.834.1115.773.3527.91
Last Close Price
0.560.7811.08168.90189.18802.80
PE Ratio
--0.17-0.23-0.61-0.89-3.31
PS Ratio
---460.6397.07596.77
PB Ratio
0.420.40-21.915.470.981.96
P/TBV Ratio
0.240.20-11.544.000.971.96
P/FCF Ratio
--0.36-0.54-2.38-0.83-3.84
P/OCF Ratio
--0.36-0.54-2.38-0.84-3.85
EV/Sales Ratio
---418.7225.50320.80
EV/EBITDA Ratio
-0.52-0.39-0.76-0.23-1.77
EV/EBIT Ratio
-0.52-0.39-0.75-0.23-1.77
EV/FCF Ratio
-0.52-0.48-2.16-0.22-2.06
Debt / Equity Ratio
0.010.03-1.550.100.030.02
Debt / EBITDA Ratio
-0.01-0.02-0.03-0.01-0.04-0.05
Debt / FCF Ratio
-0.01-0.02-0.04-0.04-0.04-0.06
Net Debt / Equity Ratio
-0.98-0.992.53-1.00-0.83-1.00
Net Debt / EBITDA Ratio
0.630.870.050.150.751.68
Net Debt / FCF Ratio
0.650.880.060.430.701.96
Asset Turnover
-000.000.010.00
Quick Ratio
4.674.730.511.947.1618.87
Current Ratio
5.735.640.872.158.9519.17
Return on Equity (ROE)
-137.78%-243.94%-714.95%-255.36%-72.35%-72.52%
Return on Assets (ROA)
-109.02%-160.03%-327.97%-211.97%-67.09%-67.24%
Return on Invested Capital (ROIC)
-7980.68%2889.39%2849.77%-1888.25%-1296.40%-25930.90%
Return on Capital Employed (ROCE)
-132.64%-232.05%-714.33%-256.03%-72.20%-71.48%
Earnings Yield
-406.44%-582.23%-432.13%-163.06%-112.75%-30.23%
FCF Yield
-386.10%-276.39%-185.19%-42.04%-120.28%-26.03%
Buyback Yield / Dilution
-797.06%-877.24%-194.35%-11.97%-3.40%-106.24%
Total Shareholder Return
-797.06%-877.24%-194.35%-11.97%-3.40%-106.24%
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q